Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$240.94
-11.10-4.40%
al cierre: -
$240.00
-0.94-0.39%
After hour: 6:12 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Accenture PLC ha un obiettivo di prezzo di consenso pari a $312.08, stabilito in base alle ultime valutazioni degli analisti di 24. Le ultime 3 valutazioni degli analisti sono state rilasciate da Mizuho, BMO Capital y Goldman Sachs il septiembre 29, 2025, septiembre 26, 2025 y septiembre 26, 2025. Con un obiettivo di prezzo medio di $303 tra le Mizuho, BMO Capital y Goldman Sachs, c'è un implicito 26.25% upside per Accenture PLC da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Mizuho
BMO Capital
Goldman Sachs
Evercore ISI Group
TD Cowen
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Accenture
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/29/2025 | 28.75% | Mizuho | $348 → $309 | Maintains | Outperform | |||
09/26/2025 | 12.5% | BMO Capital | $325 → $270 | Maintains | Market Perform | |||
09/26/2025 | 37.5% | Goldman Sachs | $370 → $330 | Maintains | Buy | |||
09/26/2025 | 16.67% | Evercore ISI Group | $300 → $280 | Maintains | Outperform | |||
09/26/2025 | 22.92% | TD Cowen | $313 → $295 | Maintains | Buy | |||
09/26/2025 | 18.75% | RBC Capital | $372 → $285 | Maintains | Outperform | |||
09/26/2025 | 37.5% | Baird | $350 → $330 | Maintains | Outperform | |||
09/26/2025 | 18.75% | Guggenheim | $305 → $285 | Maintains | Buy | |||
09/26/2025 | 20.83% | JP Morgan | $302 → $290 | Maintains | Overweight | |||
09/24/2025 | 25% | Evercore ISI Group | $330 → $300 | Maintains | Outperform | |||
09/24/2025 | 31.25% | UBS | $363 → $315 | Maintains | Buy | |||
09/18/2025 | 12.5% | Susquehanna | $330 → $270 | Maintains | Neutral | |||
09/17/2025 | 27.08% | Guggenheim | $335 → $305 | Maintains | Buy | |||
09/16/2025 | 31.25% | Stifel | $355 → $315 | Maintains | Buy | |||
09/16/2025 | 45.83% | Baird | $372 → $350 | Maintains | Outperform | |||
09/11/2025 | 8.33% | Deutsche Bank | $290 → $260 | Maintains | Hold | |||
09/09/2025 | 30.42% | TD Cowen | $342 → $313 | Maintains | Buy | |||
09/09/2025 | 12.92% | Morgan Stanley | $325 → $271 | Maintains | Equal-Weight | |||
09/03/2025 | 4.17% | Rothschild & Co | → $250 | Downgrade | Buy → Neutral | |||
08/20/2025 | 25.83% | JP Morgan | $334 → $302 | Maintains | Overweight | |||
07/28/2025 | — | HSBC | → $240 | Initiates | → Reduce | |||
07/17/2025 | 20.83% | Deutsche Bank | → $290 | Reinstates | → Hold | |||
07/17/2025 | 37.5% | Evercore ISI Group | → $330 | Initiates | → Outperform | |||
06/24/2025 | 35.42% | Morgan Stanley | $340 → $325 | Maintains | Equal-Weight | |||
06/24/2025 | 45% | Mizuho | $365 → $348 | Maintains | Outperform | |||
06/23/2025 | 39.17% | JP Morgan | $353 → $334 | Maintains | Overweight | |||
06/23/2025 | 39.58% | Guggenheim | $360 → $335 | Maintains | Buy | |||
06/23/2025 | 50% | Barclays | $390 → $360 | Maintains | Overweight | |||
06/23/2025 | 35.42% | BMO Capital | $355 → $325 | Maintains | Market Perform | |||
06/20/2025 | 54.17% | Goldman Sachs | $390 → $370 | Maintains | Buy | |||
06/16/2025 | 47.08% | JP Morgan | $349 → $353 | Maintains | Overweight | |||
06/12/2025 | 41.67% | Morgan Stanley | $372 → $340 | Maintains | Equal-Weight | |||
06/11/2025 | 50% | Guggenheim | $395 → $360 | Maintains | Buy | |||
06/04/2025 | 62.5% | Goldman Sachs | $415 → $390 | Maintains | Buy | |||
05/22/2025 | 64.58% | UBS | $390 → $395 | Maintains | Buy | |||
04/16/2025 | 47.92% | Piper Sandler | $364 → $355 | Maintains | Overweight | |||
03/24/2025 | 62.5% | Barclays | $415 → $390 | Maintains | Overweight | |||
03/21/2025 | 52.08% | Mizuho | $398 → $365 | Maintains | Outperform | |||
03/21/2025 | 45.42% | JP Morgan | $394 → $349 | Maintains | Overweight | |||
03/21/2025 | 47.92% | BMO Capital | $370 → $355 | Maintains | Market Perform | |||
03/21/2025 | 63.33% | RBC Capital | $399 → $392 | Maintains | Outperform | |||
03/21/2025 | 61.25% | UBS | $455 → $387 | Maintains | Buy | |||
03/21/2025 | 64.58% | Guggenheim | $400 → $395 | Maintains | Buy | |||
03/21/2025 | 55% | Baird | $390 → $372 | Maintains | Outperform | |||
03/20/2025 | 72.92% | Goldman Sachs | $430 → $415 | Maintains | Buy | |||
03/20/2025 | 51.67% | Piper Sandler | $396 → $364 | Maintains | Overweight | |||
03/19/2025 | 65.83% | Mizuho | $428 → $398 | Maintains | Outperform | |||
03/18/2025 | 54.17% | BMO Capital | $425 → $370 | Maintains | Market Perform | |||
03/17/2025 | 55% | Morgan Stanley | $380 → $372 | Maintains | Equal-Weight | |||
03/17/2025 | 62.5% | Baird | $390 → $390 | Upgrade | Neutral → Outperform | |||
03/14/2025 | 65% | Piper Sandler | $429 → $396 | Maintains | Overweight | |||
03/03/2025 | 64.17% | JP Morgan | $370 → $394 | Maintains | Overweight | |||
02/26/2025 | 58.33% | Stifel | $390 → $380 | Maintains | Buy | |||
01/31/2025 | 58.33% | Morgan Stanley | $335 → $380 | Maintains | Equal-Weight | |||
01/21/2025 | 47.92% | Jefferies | $385 → $355 | Maintains | Hold | |||
12/20/2024 | 78.33% | Mizuho | $395 → $428 | Maintains | Outperform | |||
12/20/2024 | 77.08% | BMO Capital | $390 → $425 | Maintains | Market Perform | |||
12/20/2024 | 60.42% | Jefferies | $355 → $385 | Maintains | Hold | |||
12/20/2024 | 89.58% | UBS | $450 → $455 | Maintains | Buy | |||
12/19/2024 | 79.17% | Goldman Sachs | $420 → $430 | Maintains | Buy | |||
12/19/2024 | 78.75% | Piper Sandler | $422 → $429 | Maintains | Overweight | |||
12/16/2024 | 65% | JP Morgan | $370 → $396 | Maintains | Overweight | |||
12/12/2024 | 75.83% | Piper Sandler | $395 → $422 | Maintains | Overweight | |||
12/10/2024 | 66.67% | Guggenheim | $395 → $400 | Maintains | Buy | |||
12/06/2024 | 75% | Goldman Sachs | $370 → $420 | Upgrade | Neutral → Buy | |||
12/03/2024 | 54.17% | Baird | $370 → $370 | Reiterates | Neutral → Neutral | |||
09/30/2024 | 64.58% | Mizuho | $365 → $395 | Maintains | Outperform | |||
09/30/2024 | 72.92% | Barclays | $350 → $415 | Maintains | Overweight | |||
09/30/2024 | 66.67% | TD Cowen | $321 → $400 | Upgrade | Hold → Buy | |||
09/27/2024 | 39.58% | Morgan Stanley | $300 → $335 | Maintains | Equal-Weight | |||
09/27/2024 | 72.92% | UBS | $400 → $415 | Maintains | Buy | |||
09/27/2024 | 64.58% | Guggenheim | $380 → $395 | Maintains | Buy | |||
09/27/2024 | 62.5% | BMO Capital | $380 → $390 | Maintains | Market Perform | |||
09/27/2024 | 62.08% | RBC Capital | $377 → $389 | Maintains | Outperform | |||
09/27/2024 | 50% | Susquehanna | $350 → $360 | Maintains | Neutral | |||
09/27/2024 | 61.67% | B of A Securities | $365 → $388 | Maintains | Buy | |||
09/27/2024 | 54.17% | Baird | $350 → $370 | Maintains | Neutral | |||
09/26/2024 | 64.58% | Piper Sandler | $329 → $395 | Upgrade | Neutral → Overweight | |||
09/24/2024 | 54.17% | JP Morgan | $376 → $370 | Maintains | Overweight | |||
09/20/2024 | 37.08% | Piper Sandler | $320 → $329 | Maintains | Neutral | |||
09/18/2024 | 52.08% | Mizuho | $352 → $365 | Maintains | Outperform | |||
09/17/2024 | 68.75% | Citigroup | $350 → $405 | Maintains | Buy | |||
09/12/2024 | 33.75% | TD Cowen | $293 → $321 | Maintains | Hold | |||
09/06/2024 | 56.67% | JP Morgan | $330 → $376 | Maintains | Overweight | |||
07/19/2024 | 66.67% | UBS | $400 → $400 | Upgrade | Neutral → Buy | |||
07/17/2024 | 46.67% | Mizuho | $350 → $352 | Maintains | Outperform | |||
06/26/2024 | 25% | Morgan Stanley | $382 → $300 | Downgrade | Overweight → Equal-Weight | |||
06/24/2024 | 39.58% | Goldman Sachs | → $335 | Initiates | → Neutral | |||
06/21/2024 | 66.67% | Morgan Stanley | $400 → $400 | Maintains | Overweight | |||
06/21/2024 | 22.08% | TD Cowen | $294 → $293 | Maintains | Hold | |||
06/21/2024 | 45.83% | BMO Capital | $375 → $350 | Maintains | Market Perform | |||
06/21/2024 | 45.83% | Susquehanna | $360 → $350 | Maintains | Neutral | |||
06/20/2024 | 45.83% | Citigroup | $340 → $350 | Maintains | Buy | |||
06/20/2024 | 33.33% | Piper Sandler | $320 → $320 | Maintains | Neutral | |||
06/18/2024 | 45.83% | Mizuho | $398 → $350 | Maintains | Buy | |||
06/17/2024 | 45.83% | Barclays | $390 → $350 | Maintains | Overweight | |||
06/17/2024 | 33.33% | Piper Sandler | $379 → $320 | Maintains | Neutral | |||
06/12/2024 | 45.83% | Wedbush | $400 → $350 | Maintains | Outperform | |||
06/12/2024 | 41.67% | Stifel | $395 → $340 | Maintains | Buy | |||
06/11/2024 | 22.5% | TD Cowen | $350 → $294 | Maintains | Hold |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Accenture (ACN)?
El último precio objetivo de Accenture (NYSE:ACN) fue comunicado por Mizuho el septiembre 29, 2025. La firma de analistas fijó un precio objetivo para $309.00 que espera ACN a rise dentro de 12 meses (un posible 28.75% upside). 66 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Accenture (ACN)?
La última calificación de analistas para Accenture (NYSE:ACN) fue proporcionada por Mizuho, y Accenture mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Accenture (ACN)?
La última revisión al alza de Accenture PLC se produjo en marzo 17, 2025, cuando Baird elevó su precio objetivo a $390. Baird anteriormente tenía a neutral para Accenture PLC.
¿Cuándo fue la última revisión a la baja de Accenture (ACN)?
La última revisión a la baja de Accenture PLC se produjo en septiembre 3, 2025, cuando Rothschild & Co cambió su precio objetivo de N/A a $250 para Accenture PLC.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Accenture (ACN)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Accenture, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Accenture se registró el septiembre 29, 2025, por lo que la próxima calificación estará disponible en torno al septiembre 29, 2026.
¿Es correcta la calificación de los analistas sobre Accenture (ACN)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Accenture (ACN) fue un mantuvo con un precio objetivo de $348.00 a $309.00. El precio actual al que cotiza Accenture (ACN) es de $240.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.